GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway

Abstract

Background The GKN2 is a secretory protein, whose levels decrease in gastric cancer. The present study aimed to investigate the expression, function and mechanism of action of GKN2 in gastric cancer. Methods Molecular biology assays were performed to elucidate the function and underlying mechanisms of GKN2 in gastric cancer under stress-induced condition in vivo and in vitro. Clinical specimens were used to assess the correlation of GKN2 and prognosis. Results We found that overexpression of GKN2 significantly enhanced apoptosis and growth arrest in vitro. GKN2 expression increased in gastric cancer cells exposed to hydrogen peroxide and promoted reactive oxygen species-induced mitochondrial dysfunction and resulted in increased cell apoptosis via inhibition of NF-κB signaling pathway and activation of JNK signaling pathway through the direct interaction of GKN2 with Hsc70. Trefoil factor 1 might contribute to the tumor suppressing effects of GKN2. MiR-216a downregulated GKN2 expression. GKN2 also inhibited xenograft tumor growth and was an independent and significant prognostic factor for patients with gastric cancer treated with oxaliplatin. Conclusions Taken together, our data indicate that GKN2 may increase sensitivity of GC cells to the drugs which increase ROS levels in tumors. Inhibition of the interaction between GKN2 and Hsc70 could attenuate the effects induced by GKN2. GKN2 overexpression could be used to determine the subgroup of patients to obtain the more favorable outcome of oxaliplatin treatment and may be used as biomarker of the prognosis of this cancer. Electronic supplementary material The online version of this article (10.1186/s13046-019-1336-3) contains supplementary material, which is available to authorized users.

A Correlation Study of Prognostic Risk Prediction for Colorectal Cancer Based on Autophagy Signature Genes

“…In a previous study, HSPA8 was found to be important for glioblastoma, and knockdown of HSPA8 interferes with the tumorigenic properties of glioblastoma cells ectopically overexpressing nesting proteins ( 16 ). In gastric cancer, HSPA8 interacts with GKN2 to promote oxidative stress-induced apoptosis, inhibit the NF-κB signaling pathway, and activate the JNK signaling pathway ( 17 ). MAPK9 is a member of the MAP kinase family and acts as an integration point for a variety of biochemical signals involved in various cellular processes such as proliferation, differentiation, transcriptional regulation and development.…”

RNA Sequencing of Early-Stage Gastric Adenocarcinoma Reveals Multiple Activated Pathways and Novel Long Non-Coding RNAs in Patient Tissue Samples

“…Both GKN1 and GKN2 have been identified as novel biomarkers for GC as have been found to be downregulated in GC patients. These genes are involved in the homeostatic regulation of the gastric mucosa (28)(29)(30). Several studies have shown a decrease in levels of GKN1 and GKN2 in gastric tumor tissues and GC cell lines.…”

TIPRL, a Novel Tumor Suppressor, Suppresses Cell Migration, and Invasion Through Regulating AMPK/mTOR Signaling Pathway in Gastric Cancer

“…Moreover, it has been reported that miR-383 promotes cholangiocarcinoma cell invasion and proliferation by suppressing IRF1 (31). More importantly, in gastric cancer, miR-216a is significantly upregulated (32), and elevation of miR-216a would favor a worse clinical outcome (33). Additionally, elevated miR-216a-3p activates the NF-κB signaling pathway through targeting RUNX1, contributing to metastatic potential of gastric cancer (34).…”